Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.58 |
| ▸ | HPGD | P15428 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | APP | P05067 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.47 |
| ▸ | PARP1 | P09874 | 4/20 | 0.45 |
| ▸ | GPR3 | P46089 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.45 |
| ▸ | TNKS | O95271 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29844822 | 0.76 | KDM4E (0.58) | KDM4EALDH1A1HSD17B10HPGDTSHR | |
| SCHEMBL30293081 | 0.76 | ALDH1A1 (0.58) | KDM4EALDH1A1HSD17B10HPGDTSHR | |
| SCHEMBL6099088 | 0.76 | KDM4E (0.58) | KDM4EALDH1A1HSD17B10HPGDTSHR | |
| SCHEMBL3139711 | 0.76 | KDM4E (0.58) | KDM4EALDH1A1HSD17B10HPGDTSHR | |
| SCHEMBL554709 | 0.76 | KDM4E (0.58) | KDM4EALDH1A1HSD17B10HPGDTSHR | |
| SCHEMBL530191 | 0.76 | ALDH1A1 (0.58) | KDM4EALDH1A1HSD17B10HPGDTSHR | |
| Benzoylenurea SCHEMBL29947820 | 0.76 | ALDH1A1 (0.58) | KDM4EALDH1A1HSD17B10HPGDTSHR | |
| SCHEMBL4413903 | 0.76 | KDM4E (0.58) | KDM4EALDH1A1HSD17B10HPGDTSHR | |
| SCHEMBL196018 | 0.76 | KDM4E (0.58) | KDM4EALDH1A1HSD17B10HPGDTSHR | |
| SCHEMBL1867417 | 0.76 | ALDH1A1 (0.58) | KDM4EALDH1A1HSD17B10HPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115666240-A | Fungicidal compositions | 先正达农作物保护股份公司 | 2023-01-31 | — | — | CN | claimed |
| CN-110740644-B | Fungicidal compositions | 先正达参股股份有限公司 | 2021-09-28 | — | — | CN | claimed |
| CN-110740644-A | Fungicidal compositions | 先正达参股股份有限公司 | 2020-01-31 | — | — | CN | claimed |
| CN-121586714-A | Connected bicyclic compounds for control and combating invertebrate pests | FMC公司 | 2026-02-27 | — | — | CN | disclosed |
| CN-115702153-B | Microbiocidal derivatives | 先正达农作物保护股份公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-120004791-A | Quaternary ring amide compound and application thereof | 青岛清原化合物有限公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-119998269-A | Microbiocidal pyrazole derivatives | 先正达农作物保护股份公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-119998270-A | Microbiocidal pyrazole derivatives | 先正达农作物保护股份公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-119907790-A | Pyrazole amide insecticidal agents | FMC公司 | 2025-04-29 | — | — | CN | disclosed |
| CN-119855495-A | New application of fluxapyroxad hydroxylamine | 先正达农作物保护股份公司 | 2025-04-18 | — | — | CN | disclosed |
| CN-119677724-A | Crystalline forms of 1,2, 4-oxadiazole fungicides | 先正达农作物保护股份公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-110799035-A | Fungicidal compositions | 先正达参股股份有限公司 | 2020-02-14 | — | — | CN | disclosed |
| CN-110770223-A | Pesticidally active pyrazole derivatives | 先正达参股股份有限公司 | 2020-02-07 | — | — | CN | disclosed |
| CN-110740644-A | Fungicidal compositions | 先正达参股股份有限公司 | 2020-01-31 | — | — | CN | disclosed |
| CN-110709395-A | Microbicidal oxadiazole derivatives | 先正达参股股份有限公司 | 2020-01-17 | — | — | CN | disclosed |
| US-7081460-B2 | Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2006-07-25 | — | — | US | disclosed |
| EP-1389205-B1 | QUINAZOLINE AND QUINAZOLINE-LIKE COMPOUNDS FOR THE TREATMENT OF INTEGRIN-MEDIATED DISORDERS | ORTHO MCNEIL PHARMACEUTICAL RE (US) | 2005-12-21 | — | — | EP | disclosed |
| EP-1389205-A1 | QUINAZOLINE AND QUINAZOLINE-LIKE COMPOUNDS FOR THE TREATMENT OF INTEGRIN-MEDIATED DISORDERS | Ortho-McNeil Pharmaceutical Research Inc. (US) | 2004-02-18 | — | — | EP | disclosed |
| US-20030139398-A1 | Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2003-07-24 | — | — | US | disclosed |
| WO-2002081467-A1 | QUINAZOLINE AND QUINAZOLINE-LIKE COMPOUNDS FOR THE TREATMENT OF INTEGRIN-MEDIATED DISORDERS | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2002-10-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030139398-A1 | Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders | ITGB2, ITGB5, ITGB3 | KDM4E 3753/4885ALDH1A1 2165/4885HSD17B10 4658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.